- NEWS
New York City researchers hope antibody-rich plasma can keep people out of intensive care.
Hospitals in New York City are gearing up to use the blood of people who have recovered from COVID-19 as a possible antidote for the disease. Researchers hope that the century-old approach of infusing patients with the antibody-laden blood of those who have survived an infection will help the metropolis — now the US epicentre of the outbreak — to avoid the fate of Italy, where intensive-care units (ICUs) are so crowded that doctors have turned away patients who need ventilators to breathe.
References
Casadevall, A. and Pirofski, L. J. Clin. Invest. https://doi.org/10.1172/JCI138003 (2020).
Cheng Y. et al. Eur. J. Clin. Microbiol. Infect. Dis. 1, 44–46 (2005).
Mupapa, K. et al. J. Infect. Dis. 17, S18–S23 (1999).
Van Griensven, J. et al. N. Engl. J. Med. 374, 33–42 (2015).